“We … that myricetin inhibited mouse T lymphocyte activation by bead‐immobilized anti‐CD3 and anti‐CD28 monoclonal antibodies, as indicated by a dose‐dependent reduction in cell proliferation and decreased synthesis of interferon‐γ , interleukin (IL)‐2, IL‐4, and IL‐17 associated with different T helper cell subsets.”